Takeda Pharmaceutical annual debt-to-equity ratio
2018
2019
2020
2021
2022
2023
2024
2025
2026
Takeda Pharmaceutical Debt-to-Equity Ratio Growth & History (TAK)
Takeda Pharmaceutical's debt-to-equity ratio was 0.66 for fiscal 2026.
View full Takeda Pharmaceutical company overviewTakeda Pharmaceutical annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | 0.66 | −0.08 | −10.45% |
| 2025 | 2025-03-31 | 0.73 | −0.02 | −2.32% |
| 2024 | 2024-03-31 | 0.75 | −0.01 | −1.82% |
| 2023 | 2023-03-31 | 0.77 | −0.08 | −9.61% |
| 2022 | 2022-03-31 | 0.85 | −0.13 | −13.66% |
| 2021 | 2021-03-31 | 0.98 | −0.18 | −15.23% |
| 2020 | 2020-03-31 | 1.16 | 0.05 | +4.21% |
| 2019 | 2019-03-31 | 1.11 | 0.62 | +124.90% |
| 2018 | 2018-03-31 | 0.49 | — | — |
Takeda Pharmaceutical quarterly debt-to-equity ratio
Q4.18
Q4.19
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | 0.65 | −0.00 | −0.41% |
| Q4 2026 | 2026-03-31 | 0.66 | −0.08 | −10.45% |
| Q3 2026 | 2025-12-31 | 0.64 | — | — |
| Q2 2026 | 2025-09-30 | 0.65 | — | — |
| Q1 2026 | 2025-06-30 | 0.66 | — | — |
| Q4 2025 | 2025-03-31 | 0.73 | −0.02 | −2.32% |
| Q4 2024 | 2024-03-31 | 0.75 | −0.01 | −1.82% |
| Q4 2023 | 2023-03-31 | 0.77 | −0.08 | −9.61% |
| Q4 2022 | 2022-03-31 | 0.85 | −0.13 | −13.66% |
| Q4 2021 | 2021-03-31 | 0.98 | −0.18 | −15.23% |
| Q4 2020 | 2020-03-31 | 1.16 | 0.05 | +4.21% |
| Q4 2019 | 2019-03-31 | 1.11 | 0.62 | +124.90% |
| Q4 2018 | 2018-03-31 | 0.49 | — | — |
Takeda Pharmaceutical debt-to-equity ratio trends
Over the last five fiscal years, Takeda Pharmaceutical's debt-to-equity ratio decreased from 0.98 to 0.66, a change of −0.32. The latest reported quarter, Q1 2027, shows 0.65.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Takeda Pharmaceutical source filings ↗